Deals Activity: Moderate
Restructuring Activity: High
Q1 of 2023 saw 6 deals in the Chemicals sector. This was a marginal increase on the previous quarter but is broadly comparable with industry activity over the past few years. Notable deals executed during Q1 2023 include:
- Solenis’ acquisition of disinfectant manufacturer Diversey through a $4.6bn LBO.
- In the UK, Hammond Chemicals’ receipt of an undisclosed amount of development capital from Euston Capital Trust.
The deals activity in this sector has been influenced by:
- Consolidation – in a mature sector and with downward pressure on margins brought about by rising input costs, operators have sought merger opportunities as means of reducing costs.
- Portfolio extension – market operators have sought to widen their product portfolios through acquisition of complementary entities.
Restructuring activity in this sector remains relatively high. Volatile energy prices, higher costs, shortages of key input materials and changing global trading patterns have created some uncertainty. In addition, chemicals businesses are having to respond rapidly to the climate emergency, placing a focus on sustainable production practices and limiting environmental harm.
Deals activity in Chemicals
Restructuring activity in Chemicals
Find Your Expert
James Fagan is Head of ENR Cluster, which includes Chemicals as one of four core segments. Matthew Courtman-Stock leads Interpath's approach to the Chemicals sector nationally. For a full list of our senior people with experience in this sector use the button below.Our senior team